BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  XLT Biopharmaceuticals Ltd. Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

  September 10, 2007

   · 

  9 min read
• Biotech Bay

  FONAR Corporation: Revolutionary FONAR UPRIGHT Multi-Position MRI Brought to San Jose (Silicon Valley) by Vision Upright MRI

  September 10, 2007

   · 

  1 min read
• Drug Development

  Pharmasset, Inc. Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers

  September 10, 2007

   · 

  7 min read
• Drug Development

  KOSAN Biosciences, Inc.'s Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial

  September 10, 2007

   · 

  7 min read
• Business

  VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration

  September 10, 2007

   · 

  1 min read
• Drug Development

  EntreMed, Inc. Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer

  September 10, 2007

   · 

  4 min read
• Policy

  MedImmune, Inc. Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)

  September 10, 2007

   · 

  3 min read
• Business

  Peregrine Pharmaceuticals, Inc. Reports First Quarter Fiscal Year 2008 Financial Results

  September 10, 2007

   · 

  8 min read
• Drug Development

  Pharmasset, Inc. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients

  September 10, 2007

   · 

  8 min read
• Resverlogix Corporation: First Ever Therapy Targets Optic Nerve Head for Glaucoma

  September 10, 2007

   · 

  1 min read